At the time of diagnosis | Staff (percent) |
Median age, year | 70 (56 - 79) |
median PSA, ng/ml | 25.1 (4.9 - 3609) |
Metastatic disease, n (%) | 3 (37.5) |
Local treatment of the primary disease, n (%) | 6 (75) |
Androgenic castration, n (%) | 8 (100) |
At the time of oligoprogression |
|
Median age, year | 73 (60 - 81) |
median PSA, ng/ml | 3.11 (2.5 - 43.8) |
Diagnostic imaging, n (%) |
|
PET-CT (PSMA/Choline) | 8 (100) |
Conventional imaging | 1 (12.5) |
Number of progressive lesions, n (%) |
|
1 | 7 (87.5) |
2 | 1 (12.5) |
Types of progressive lesions, n (%) |
|
Bone | 8 (87.5) |
Local relapse | 1 (12.5) |
Treatment, n (%) |
|
Radiotherapy | 8 (100) |
Radiotherapy technique |
|
Stereotaxis | 7 (77.77) |
3D | 2 (22.23) |
Fractionation, n lesion |
|
10 Gy × 3 fractions 4 Gy × 5 fractions 12 Gy × 3 fractions 23 Gy × 2 fractions | 6 (1) 1 (1) 1 (1) 1(1) |